Rubius Therapeutics Inc (NASDAQ:RUBY)

0.2804
Delayed Data
As of Feb 03
 -0.0135 / -4.59%
Today’s Change
0.14
Today|||52-Week Range
6.54
+60.23%
Year-to-Date
No recent news for Rubius Therapeutics Inc.

Today’s Trading

Previous close0.29
Today’s open0.29
Day’s range0.28 - 0.31
Volume21,075
Average volume (3 months)1,169,502
Market cap$26.6M
Data as of 3:59pm ET, 02/03/2023

Growth & Valuation

Earnings growth (last year)-7.42%
Earnings growth (this year)+19.28%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.15

Competitors

 Today’s
change
Today’s
% change
VCNXVaccinex Inc0.000.00%
CMMBChemomab Therapeutic...0.000.00%
----
----
Data as of 3:59pm ET, 02/03/2023

Financials

Last reporting dateNovember 16, 2022
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$0.00
Annual profit (last year)-$196.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts